N. Fischer-Durand et al. / Journal of Organometallic Chemistry 668 (2003) 59Á
/
66
61
Me2SO): d 1.05 (3H, t, Jꢂ
/
6.5 Hz, CH3 Et); 3.2 (2H, q,
CH2Ã
NH); 8.3 (1H, t, Jꢂ
MHz, Me2SO): d 22.2; 28.2; 40.5; 42.3; 73.0; 81.3; 164.5;
285
[MHꢁ]; Anal. Calc. for C11H15ClN6O: C, 46.73; H,
5.35; N, 29.72. Found: C, 46.96; H, 5.61; N, 29.17%.
Compound 6: Colorless oil which crystallized at 4 8C
(0.17 g, 50%); m.p.: 104 8C; 1H-NMR (250 MHz,
CDCl3): d 1.14 (6H, m, CH3 iPr); 1.31 (2H, m, CH2);
/
CÅ
/
CH); 3.9 (1H, m, HC(CH3)2); 7.7Á
/
7.9 (2H, m,
Jꢂ
/
6.4 Hz, CH2 Et); 3.86 (2H, m, CH2 Gly); 7.9 (2H, m,
NH); 12.5 (1H, broad s, CO2H); 13C-NMR (50 MHz,
Me2SO): d 14.6; 35.45; 42.6; 135.35; 165.3; 165.8; 168;
/
5.5 Hz, NH amide); 13C-NMR (50
165.9; 168.1; 168.9. MS (CIꢁ
/
CH4) m/z: 283Á
/
171.6. MS (CIꢁ
/
NH3) m/z: 232Á
/
234 [MHꢁ].
2.5.1.2. 2-Chloro-4-(isopropylamino)-6-
(carboxymethylamino)-s-triazine (2). Yield: 1.4 g,
about 22%; m.p.: 205 8C (dec.); H-NMR (200 MHz,
1
Me2SO): d 1.08 (6H, d, Jꢂ
s large, CH2 Gly); 3.94 (1H, m, HC(CH3)2); 7.7Á8.0
(2H, m, NH); 12.5 (1H, broad s, COOH); 13C-NMR (50
/
6.5 Hz, CH3 iPr); 3.85 (2H,
1.60 (4H, m, CH2); 2.13 (3H, m, CH2Ã
CH); 3.31 (2H, m, NHÃCH2ÃR); 3.97 (2H, dd, Jꢂ
and 2.5 Hz, CH2ÃCÅCH); 4.08 (1H, m, HC(CH3)2);
5.62 (1H, d, Jꢂ7.75 Hz, NH amine); 6.13 (1H, m, NH
amine); 6.68 (1H, t, Jꢂ
5.87 Hz, NH amide); 13C-NMR
/
CONH and CÅ
/
/
/
/
/
5.25
/
/
MHz, Me2SO): d 22.1; 22.5; 42.4; 164.5; 171.5. MS
248 [MHꢁ].
/
(CIꢁ
/
CH4) m/z: 246Á
/
/
(60 MHz, CDCl3): d 22.7; 23.2; 25.6; 26.8; 29.5; 36.5;
41.0; 43.3; 71.8; 80.1; 165.1; 166.1; 168.3; 173.0. MS
2.5.2. 2-Chloro-4-(isopropylamino)-6-
(carboxypenthylamino)-s-triazine (3)
Previously described [7,19].
(CIꢁ
/
CH4) m/z: 339Á
341 [MHꢁ]; Anal. Calc. for
C15H23ClN6O: C, 53.14; H, 6.84; N, 24.80. Found C,
53.33; H, 6.88; N, 24.52%.
/
2.5.3. 2-Chloro-4-(alkylamino)-6-[N(3-
propynamido)alkylamino]-s-triazines (4), (5), and (6):
general procedure
2.5.4. Complexation of propargylic compounds 4 and 5
with Co2(CO)8: general procedure
The previously prepared acid 1, 2 or 3 (0.907 mmol)
was dissolved in anhydrous DMF (12 ml) under Ar. The
In a three-neck round bottomed flask protected from
light and under argon, a propargylic derivative (0.409
mmol) was dissolved in anhydrous DMF (9 ml).
Co2(CO)8 (0.15 g, one equivalent) was added three times
at 15 min intervals and the reaction was monitored by
resulting solution was cooled to ꢀ
xysuccinimide (0.136 g, 1.3 equivalents), EDAC×
/
15 8C, then hydro-
HCl
/
(0.226 g, 1.3 equivalents), and iPr2EtN (0.205 ml, 1.3
equivalents) were added. The mixture was stirred for 1 h
TLC (EtOAc, Rfꢂ
/
0.8 for 7, Rfꢂ0.9 for 8). After 90
/
at ꢀ
/
15 8C, then for 2 h at 0 8C, and allowed to stand at
min the reaction mixture was directly flash chromato-
graphed under Ar on SiO2 (15 cm length, EtOAc). The
combined fractions containing the expected compound
were concentrated and again flash chromatographed to
yield an orange powder.
r.t. overnight. The colored solution (yellow to orange
depending on the starting acid) was cooled to 0 8C, and
propargylamine (74.7 mL, 1.2 equivalents) was added
under Ar. The solution was stirred at 0 8C for 3 h.
For compound 4, the solution was poured into a flask
cooled on an ice bath, and cold H2O was added (15 ml).
The precipitate was filtered off, washed with cold water
and dried to yield an off-white powder (0.65 g, 65%).
For compounds 5 and 6, the solutions were diluted
with EtOAc (20 ml), and H2O was added (20 ml). The
Compound 7: 50 mg (22%); IR (CHCl3): 2031.6;
1
2058.6; 2097; H-NMR (400 MHz, Me2SO): d 1.0 (3H,
m, CH3); 3.2 (2H, m, CH2 Et); 3.8 (2H, broad s, CH2
Gly); 4.5 (2H, broad d, CH2Ã
/
CÅ
/
CH); 6.6 (1H, s, CÅ
/
CH); 7.8 (2H, m, NH amines); 8.6 (1H, NH amide); 13C-
NMR (100 MHz, Me2SO): d 14.3; 35.0; 40.9; 43.5; 73.0;
95.2; 165.1; 165.8; 167.7; 168.8; 200.0. MS (FABꢁ) m/z:
aqueous phases were extracted with EtOAc (3ꢃ50 ml).
The organic phases were dried (Na2SO4), and evapo-
rated to dryness under reduced pressure. The crude
/
555Á
557 [MHꢁ].
/
Compound 8: 69 mg (30%)ꢁ50 mg of starting
/
products were purified on SiO2 (EtOAc, Rfꢂ
both compounds).
Compound 4: m.p.: 264 8C; 1H-NMR (200 MHz,
Me2SO): d 1.0 (3H, t, Jꢂ7.1 Hz, CH3 Et); 3.1 (1H,
broad s, CÅCH); 3.2 (2H, q, Jꢂ6.7 Hz, CH2 Et); 3.8
/0.6 for
compound; IR (CHCl3): 2031.9; 2058.7; 2097.2; 1H-
NMR (400 MHz, Me2SO): d 1.2 (6H, broad s, CH3
iPr); 4.1 (3H, m, CH2 GlyꢁHC(CH3)2); 4.7 (2H, broad
/
/
s, CH2Ã
/
CÅ
/
CH); 6.4 (1H, broad s, CÅ
/
CH); 6.7Á6.9 (2H,
/
/
/
m, NH amines); 8.1 (1H, broad s, NH amide); 13C-
(4H, m, CH2 Glyꢁ
/
CH2Ã
/
CÅ
/
CH); 7.8Á
/
7.9 (2H, broad m,
NMR (100 MHz, Me2SO): d 22.3; 42.0; 43.1; 44.6; 73.4;
NH amines); 8.32 (1H, broad m, NH amide); 13C-NMR
(50 MHz, Me2SO): d 14.5; 28.2; 35.3; 43.9; 73.0; 81.4;
95.5; 165.7; 167.1; 169.2; 169.5; 200.6; MS (CIꢁ
/
NH3)
m/z: 569Á
/
571 [MHꢁ].
165.2; 166.0; 168.1; 168.9. MS (CIꢁ
/
CH4) m/z: 269Á271
/
[MHꢁ]; Anal. Calc. for C10H13ClN6O: C, 44.69; H,
4.87; N, 31.27. Found: C, 45.05; H, 5.22; N: 30.52%.
Compound 5: Off-white powder (0.1 g, 39%); m.p.:
2.5.5. Complexation of propargylic compound 6 with
Co2(CO)8
In a three-neck round bottomed flask protected from
light and under Ar, propargylic compound 6 (72 mg,
1
213 8C; H-NMR (200 MHz, Me2SO): d 1.07 (6H, m,
CH3 iPr); 3.1 (1H, m, CÅ
/
CH); 3.8 (4H, m, CH2 Glyꢁ
/
2.13ꢃ
10ꢀ4 mol) was dissolved in anhydrous THF (4
/